Differential binding properties of oripavines at cloned μ- and δ-opioid receptors

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922 · see citing works

Opiates and endogenous opioid peptides

Kelly, J. S., & Dingledine, R. J. (1977) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(77)90262-6 · Cited by 1,290 · see citing works

Receptor-effector coupling by G proteins

Birnbaumer, L., Abramowitz, J., & Brown, A. M. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90007-y · Cited by 1,121 · see citing works

Pharmacologic Analysis of Drug Receptor Interaction

Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 932 · see citing works

International Union of Pharmacology. XII. Classification of opioid receptors

Bn, D., Cesselin, F., Raghubir, R., Reisine, T., Bradley, P. B., Portoghese, P. S., & Hamon, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06958-3 · Cited by 732 · see citing works

AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT

Cowan, A., Lewis, J. W., & Macfarlane, I. R. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07532.x · Cited by 529 · see citing works

Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via alpha-adrenergic, cholinergic, and opiate receptors in neuroblastoma x glioma hybrid cells.

Kurose, H., Katada, T., Amano, T., et al. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32507-9 · Cited by 495 · see citing works

Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.

Traynor, J. R., & Nahorski, S. R. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08634-1 · Cited by 463 · see citing works

THE ANIMAL PHARMACOLOGY OF BUPRENORPHINE, AN ORIPAVINE ANALGESIC AGENT

Cowan, A., Doxey, J. C., & Harry, E. J. R. (1977) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1977.tb07533.x · Cited by 329 · see citing works

A Neuroblastoma × Glioma Hybrid Cell Line with Morphine Receptors

Klee, W. A., & Nirenberg, M. W. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.9.3474 · Cited by 317 · see citing works

Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.

Toll, L., Berzetei-Gurske, I. P., Polgar, W. E., Brandt, S. R., Adapa, I. D., Rodriguez, L., Rw, S., Haggart, D., O’Brien, A. D., White, A. E., et al. (1998) · PubMed · doi:10.7270/q23j3bh2 · Cited by 243 · see citing works

Differential Regulation by Guanine Nucleotides of Opiate Agonist and Antagonist Receptor Interactions

Childers, S. R., & Snyder, S. H. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb11184.x · Cited by 209 · see citing works

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

Emmerson, P. J., Clark, M. J., Mansour, A., Akil, H., Woods, J. H., & Medzihradsky, F. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20761-3 · Cited by 182 · see citing works

A single residue, aspartic acid 95, in the delta opioid receptor specifies selective high affinity agonist binding.

Kong, H., Raynor, K., Yasuda, K., Moe, S. T., Portoghese, P. S., Bell, G. I., & Reisine, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49424-6 · Cited by 148 · see citing works

Buprenorphine has potent kappa opioid receptor antagonist activity

LEANDER, J. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90112-2 · Cited by 140 · see citing works

ACTIONS OF ETORPHINE HYDROCHLORIDE, (M99): A POTENT MORPHINE‐LIKE AGENT

Blane, G. F., Boura, A. L. A., FITZGERALD, A. E., et al. (1967) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1967.tb02108.x · Cited by 120 · see citing works

Stimulation of Guanosine-5′-O-(3-[35S]Thio)Triphosphate Binding by Endogenous Opioids Acting at a Cloned Mu Receptor

Alt, A. J., Mansour, A., Akil, H., Medzihradsky, F., Traynor, J. R., & Woods, J. H. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37585-8 · Cited by 103 · see citing works

In vivo opiate receptor binding of oripavines to μ, σ and κ sites in rat brain as determined by an ex vivo labeling method

Richards, M. L., & Sadée, W. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90379-6 · Cited by 66 · see citing works

Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Delta Opioid Receptor

Clark, M. J., Emmerson, P. J., Mansour, A., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37088-0 · Cited by 58 · see citing works

Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.

Puttfarcken, P. S., Werling, L. L., Brown, S. R., et al. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10339-8 · Cited by 50 · see citing works

In vivo apparent affinity and efficacy estimates for ? opiates in a rat tail-withdrawal assay

Zernig, G., Young, A. M., & Walker, E. A. (1998) · Psychopharmacology · doi:10.1007/s002130050534 · Cited by 49 · see citing works

κ antagonist properties of buprenorphine in the shock titration procedure

Negus, S. S., & Dykstra, L. A. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90149-5 · Cited by 46 · see citing works

Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.

Werling, L. L., Brown, S. R., Puttfarcken, P. S., et al. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10340-4 · Cited by 43 · see citing works

ANTINOCICEPTIVE ACTIVITY OF THE NARCOTIC ANTAGONIST ANALGESICS AND ANTAGONISTIC ACTIVTY OF NARCOTIC ANALGESICS IN RODENTS

Dewey, W. L., & Harris, L. S. (1971) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29074-7 · Cited by 43 · see citing works

Differential Effects of Mg2+ and Other Divalent Cations on the Binding of Tritiated Opioid Ligands

Rodriguez, F. D., Bardajı́, E., & Traynor, J. R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09393.x · Cited by 42 · see citing works

The physiological relevance of low agonist affinity binding at opioid μ‐receptors

Carroll, J. A., Shaw, J. S., & Wickenden, A. D. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11569.x · Cited by 42 · see citing works

Mutagenesis of a Single Amino Acid in the Rat μ‐Opioid Receptor Discriminates Ligand Binding

Bot, G., Blake, A. D., Li, S., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010358.x · Cited by 34 · see citing works

Rates of onset and offset of action of narcotic analgesics in isolated preparations

Kosterlitz, H. W., Leslie, F. M., & Waterfield, A. A. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90317-9 · Cited by 32 · see citing works

BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.

Childers, S. R., Fleming, L. M., Selley, D. E., et al. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13269-0 · Cited by 32 · see citing works

Diprenorphine has agonist activity at opioid κ-receptors in the myenteric plexus of the guinea-pig ileum

Traynor, J. R., Corbett, A. D., & Kosterlitz, H. W. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90185-3 · Cited by 25 · see citing works

Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate.

Wong, C., Su, Y. F., Watkins, W. D., et al. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38986-x · Cited by 24 · see citing works

Dihydroetorphine is a μ-Receptor-selective Ligand

Wang, D., Lu, X., & Qin, B.-Y. (1995) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1995.tb05857.x · Cited by 24 · see citing works

Comparison of mu opioid receptor binding on intact neuroblastoma cells with guinea pig brain and neuroblastoma cell membranes.

Toll, L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11256-1 · Cited by 24 · see citing works

Sodium regulation of opioid agonist binding is potentiated by pertussis toxin

Wüster, M., Costa, T., Aktories, K., et al. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80247-8 · Cited by 21 · see citing works

Binding of buprenorphine to opiate receptors

Villiger, J. W. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90201-6 · Cited by 20 · see citing works

[3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate

Kurowski, M., Rosenbaum, J. S., Perry, D. C., et al. (1982) · Brain Research · doi:10.1016/0006-8993(82)90068-3 · Cited by 19 · see citing works

Antinociceptive effect of dihydroetorphine in diabetic mice

Kamei, J., Suzuki, T., Misawa, M., et al. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00013-b · Cited by 16 · see citing works

Physical separation of the agonist and antagonist forms of a mu opiate receptor ?

Jauzac, P., Puget, A., & Meunier, J. C. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90476-9 · Cited by 15 · see citing works

Lipophilicity of opioids determined by a novel micromethod

Medzihradsky, F., Emmerson, P. J., & Mousigian, C. A. (1992) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/1056-8719(92)90023-t · Cited by 12 · see citing works

Regulation of opioid antagonist and mu, kappa or delta agonist binding by guanine nucleotide and sodium.

Ishizuka, Y., & Oka, T. (1984) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.36.397 · Cited by 9 · see citing works

A brain-centric model of suicidal behavior

Mann, J. J., & Rizk, M. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081224 · Cited by 214 · see citing works

Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices

Greenwald, M., Johanson, C.-E., Bueller, J., Chang, Y., Moody, D. E., Kilbourn, M., Koeppe, R., & Zubieta, J.-K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.043 · Cited by 124 · see citing works

The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors

Hatzoglou, A., Bakogeorgou, E., & Castanas, E. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00703-2 · Cited by 94 · see citing works

Decrease in μ-opioid receptor binding capacity in rat brain after chronic PL017 treatment

Tao, P., Lee, H.-Y., Chang, L.-R., et al. (1990) · Brain Research · doi:10.1016/0006-8993(90)91231-5 · Cited by 41 · see citing works

[Binding characteristics of new synthesized opioid receptor ligands to cloned mu opioid receptors stably expressed in CHO cell].

Hu, P., Ye, C., Qiu, Z., et al. (2003) · PubMed · Cited by 1 · see citing works

Differential Regulation of two Molecular Forms of a μ-Opioid Receptor Type by Sodium Ions, Manganese Ions and by Guanyl-5′-YL Imidodiphosphate

Jauzac, P., Francès, B., Puget, A., et al. (1986) · Journal of Receptor Research · doi:10.3109/10799898609073921 · Cited by 15 · see citing works

Opioid Agonists Differentially Regulate μ-Opioid Receptors and Trafficking Proteins in Vivo

Patel, M. B., Patel, C. N., Rajashekara, V., & Yoburn, B. C. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1464 · Cited by 60 · see citing works